Literature DB >> 9929510

Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450.

W F Busby1, J M Ackermann, C L Crespi.   

Abstract

The effects of methanol, ethanol, dimethyl sulfoxide (DMSO), and acetonitrile were studied in vitro on nine individual, cDNAexpressed cytochrome P-450 activities (phenacetin O-deethylase for CYP1A1 and CYP1A2, coumarin 7-hydroxylase for CYP2A6, testosterone 6beta-hydroxylase for CYP3A4, 7-ethoxy-4-trifluoromethylcoumarin deethylase for CYP2B6, paclitaxel 6alpha-hydroxylase for CYP2C8, diclofenac 4'-hydroxylase for CYP2C9, S-mephenytoin 4-hydroxylase for CYP2C19, and (+/-)-bufuralol 1'-hydroxylase for CYP2D6) in commercially available human lymphoblastoid microsomes. These data show that specific solvents have enzyme-selective effects on P-450 activities. Methanol did not substantially inhibit (</=10%) any of the activities at 0.3%, but did inhibit CYP1A1, CYP2B6, CYP2C9, and CYP2D6 by 12 to 26% at 1%. In contrast, 0.1% ethanol inhibited CYP1A1, CYP2B6, and CYP2C19 by 20 to 30%. Ethanol at 1% did not inhibit CYP1A2, CYP3A4, CYP2C8, and CYP2C9. DMSO inhibited CYP3A4, CYP2C19, and CYP2D6 by 15 to 25% at 0.1%. However, DMSO had little effect on CYP1A2, CYP2A6, and CYP2C8. Acetonitrile, like methanol, did not inhibit any P-450 activity at 0.3% solvent except for CYP1A1 (26%) and CYP2B6 (13%). At 1%, acetonitrile decreased activities of CYP1A1 and CYP2B6 by 40 to 60%, and inhibited CYP2A6, CYP3A4, CYP2C19, and CYP2D6 activity by 10 to 20%. Acetonitrile also increased CYP2C9 activity by 10 to 15% above control values at 1 to 3% solvent. Excluding solubility considerations, methanol and acetonitrile appear to be the most suitable solvents for the introduction of substances to cytochrome P-450 incubations for in vitro metabolism studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9929510

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  42 in total

1.  Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicity.

Authors:  Janet K Coller; Niels Krebsfaenger; Kathrin Klein; Renzo Wolbold; Andreas Nüssler; Peter Neuhaus; Ulrich M Zanger; Michel Eichelbaum; Thomas E Mürdter
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

2.  The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liver.

Authors:  Janet K Coller; Niels Krebsfaenger; Kathrin Klein; Karin Endrizzi; Renzo Wolbold; Thomas Lang; Andreas Nüssler; Peter Neuhaus; Ulrich M Zanger; Michel Eichelbaum; Thomas E Mürdter
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

3.  High-Throughput Cytochrome P450 Cocktail Inhibition Assay for Assessing Drug-Drug and Drug-Botanical Interactions.

Authors:  Guannan Li; Ke Huang; Dejan Nikolic; Richard B van Breemen
Journal:  Drug Metab Dispos       Date:  2015-08-18       Impact factor: 3.922

Review 4.  The conduct of drug metabolism studies considered good practice (II): in vitro experiments.

Authors:  Lee Jia; Xiaodong Liu
Journal:  Curr Drug Metab       Date:  2007-12       Impact factor: 3.731

Review 5.  In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions.

Authors:  Stephen Fowler; Hongjian Zhang
Journal:  AAPS J       Date:  2008-08-07       Impact factor: 4.009

6.  Evaluation of surfactants as solubilizing agents in microsomal metabolism reactions with lipophilic substrates.

Authors:  Kathleen Randall; Shun Wen Cheng; Anne Therese Kotchevar
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-09-05       Impact factor: 2.416

7.  Inhibition of Rat CYP1A2 and CYP2C11 by Honokiol, a Component of Traditional Chinese Medicine.

Authors:  Jing Li; Ming-Rui Li; Bao Sun; Cheng-Ming Liu; Jing Ren; Wen-Qian Zhi; Pei-Yu Zhang; Hai-Ling Qiao; Na Gao
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-12       Impact factor: 2.441

8.  CYP2C19 and 3A4 Dominate Metabolic Clearance and Bioactivation of Terbinafine Based on Computational and Experimental Approaches.

Authors:  Mary A Davis; Dustyn A Barnette; Noah R Flynn; Anirudh S Pidugu; S Joshua Swamidass; Gunnar Boysen; Grover P Miller
Journal:  Chem Res Toxicol       Date:  2019-04-10       Impact factor: 3.739

9.  Replacement with GABAergic steroid precursors restores the acute ethanol withdrawal profile in adrenalectomy/gonadectomy mice.

Authors:  K R Kaufman; M A Tanchuck; M N Strong; D A Finn
Journal:  Neuroscience       Date:  2010-01-06       Impact factor: 3.590

10.  Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.

Authors:  N Cazali; A Tran; J M Treluyer; E Rey; P d'Athis; J Vincent; G Pons
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.